High-Dose-Rate Brachytherapy as Monotherapy for Intermediate- and High-Risk Prostate Cancer: Clinical Results for a Median 8-Year Follow-Up.
Yoshioka Y, Suzuki O, Isohashi F, Seo Y, Okubo H, Yamaguchi H, Oda M, Otani Y, Sumida I, Uemura M, Fujita K, Nagahara A, Ujike T, Kawashima A, Yoshida K, Yamazaki H, Nonomura N, Ogawa K.
Yoshioka Y, et al. Among authors: sumida i.
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):675-82. doi: 10.1016/j.ijrobp.2015.05.044. Epub 2015 Jun 3.
Int J Radiat Oncol Biol Phys. 2016.
PMID: 26238951